Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Aug 9;183(11):E733-42.
doi: 10.1503/cmaj.101146. Epub 2011 Jul 11.

Telehealthcare for asthma: a Cochrane review

Affiliations
Meta-Analysis

Telehealthcare for asthma: a Cochrane review

Susannah McLean et al. CMAJ. .

Abstract

Background: Telehealthcare has the potential to provide care for long-term conditions that are increasingly prevalent, such as asthma. We conducted a systematic review of studies of telehealthcare interventions used for the treatment of asthma to determine whether such approaches to care are effective.

Methods: We searched the Cochrane Airways Group Specialised Register of Trials, which is derived from systematic searches of bibliographic databases including CENTRAL (the Cochrane Central Register of Controlled Trials), MEDLINE, Embase, CINAHL (Cumulative Index to Nursing and Allied Health Literature) and PsycINFO, as well as other electronic resources. We also searched registers of ongoing and unpublished trials. We were interested in studies that measured the following outcomes: quality of life, number of visits to the emergency department and number of admissions to hospital. Two reviewers identified studies for inclusion in our meta-analysis. We extracted data and used fixedeffect modelling for the meta-analyses.

Results: We identified 21 randomized controlled trials for inclusion in our analysis. The methods of telehealthcare intervention these studies investigated were the telephone and video- and Internet-based models of care. Meta-analysis did not show a clinically important improvement in patients' quality of life, and there was no significant change in the number of visits to the emergency department over 12 months. There was a significant reduction in the number of patients admitted to hospital once or more over 12 months (risk ratio 0.25 [95% confidence interval 0.09 to 0.66]).

Interpretation: We found no evidence of a clinically important impact on patients' quality of life, but telehealthcare interventions do appear to have the potential to reduce the risk of admission to hospital, particularly for patients with severe asthma. Further research is required to clarify the cost-effectiveness of models of care based on telehealthcare.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Identification of relevant literature on the use of telehealthcare for the treatment of asthma. ANZCTR = Australian New Zealand Clinical Trials Registry, CENTRAL = the Cochrane Central Register of Controlled Trials, CINAHL = Cumulative Index to Nursing and Allied Health Literature, NIHR = National Institutes of Health Research. *The 21 trials included in the final review were published across 25 reports.
Figure 2:
Figure 2:
Forest plots of the mean differences and 95% confidence intervals (CIs) in the measurement of quality of life among patients with asthma as per Juniper’s questionnaire (A), as suggested by studies investigating telehealthcare delivered by telephone only (B) and as suggested by studies investigating telehealthcare delivered by all other technologies (C). SD = standard deviation.
Figure 3:
Figure 3:
Forest plot of the risk ratios (RRs) and 95% confidence intervals (CIs) of the numbers of patients who visited the emergency department once or more over 12 months.
Figure 4:
Figure 4:
Forest plots of the risk ratios (RRs) and 95% confidence intervals (CIs) for the numbers of patients admitted to hospital once or more over 3 months (A), and the number of patients admitted to hospital once or more over 12 months (B). *Because of high heterogeneity, analysis was performed using a random effects model.

References

    1. Pearce N, Sunyer J, Cheng S, et al. Comparison of asthma prevalence in the ISAAC and the ECRHS. Eur Respir J 2000; 16:420–6 - PubMed
    1. Asher MI, Montefore S, Bjorkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma allergic rhinoconjunctivitis and eczema in childhood: ISAAC Phases One and Three repeat muli-country cross-sectional surveys. Lancet 2006;368: 733–43 - PubMed
    1. Anderson HR, Gupta R, Strachan DP, et al. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007;62:85–90 - PMC - PubMed
    1. Masoli M, Fabian D, Holt S, et al. Global burden of asthma. GINA [The Global Initiative for Asthma]; 2003 - PubMed
    1. The future of asthma. Lancet 1997;350:1113. - PubMed

Publication types

MeSH terms